Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(4):263–270. doi: 10.1155/S0962935193000365

Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases

Giamila Fantuzzi 1, Pietro Ghezzi 1,✉
PMCID: PMC2365417  PMID: 18475532

Abstract

Glucocorticoids are potent inhibitors of inflammation and endotoxic shock. This probably occurs through an inhibition of the synthesis of pro-inflammatory cytokines as well as of many of their toxic activities. Therefore, endogenous glucocorticoids (GC) might represent a major mechanism in the control of cytokine mediated pathologies. GC inhibit the synthesis of cytokines in various experimental models. Adrenalectomy or GC antagonists potentiate TNF, IL-1 and IL-6 production in LPS treated mice. GC inhibit the formation of arachidonic acid metabolites and the induction of NO synthase. They also inhibit various activities of cytokines including toxicity, haemodynamic shock and fever. Adrenalectomy sensitizes to the toxic effects of LPS, TNF and IL-1. On the other hand, GC potentiate the synthesis of several cytokine induced APP by the liver. Since many of these proteins have anti-toxic activities (antioxidant, antiprotease etc.) or bind cytokines, this might well represent a GC mediated protective feedback mechanism involving the liver. Not only do GC inhibit cytokines, but in vivo LPS and various cytokines (TNF, IL-1, IL-6) increase blood GC levels through a central mechanism involving the activation of the HPA. Thus, this neuroendocrine response to cytokines constitutes an important immunoregulatory feedback involving the brain.

Full Text

The Full Text of this article is available as a PDF (895.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABERNATHY R. S., HALBERG F., SPINK W. W. Studies on the mechanism of chlorpromazine protection against Brucella endotoxin in mice. J Lab Clin Med. 1957 May;49(5):708–715. [PubMed] [Google Scholar]
  2. Akahoshi T., Oppenheim J. J., Matsushima K. Induction of high-affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones. J Exp Med. 1988 Mar 1;167(3):924–936. doi: 10.1084/jem.167.3.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andus T., Gross V., Cäsar I., Krumm D., Hosp J., David M., Schölmerich J. Activation of monocytes during inflammatory bowel disease. Pathobiology. 1991;59(3):166–170. doi: 10.1159/000163637. [DOI] [PubMed] [Google Scholar]
  4. Anttila H. S., Reitamo S., Ceska M., Hurme M. Signal transduction pathways leading to the production of IL-8 by human monocytes are differentially regulated by dexamethasone. Clin Exp Immunol. 1992 Sep;89(3):509–512. doi: 10.1111/j.1365-2249.1992.tb06990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arend W. P., Massoni R. J. Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes. Clin Exp Immunol. 1986 Jun;64(3):656–664. [PMC free article] [PubMed] [Google Scholar]
  6. BERRY L. J., SMYTHE D. S. EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISM. VII. ENZYME INDUCTION AND CORTISONE PROTECTION. J Exp Med. 1964 Nov 1;120:721–732. doi: 10.1084/jem.120.5.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baker C. C., Chaudry I. H., Gaines H. O., Baue A. E. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983 Aug;94(2):331–335. [PubMed] [Google Scholar]
  8. Barber A. E., Coyle S. M., Marano M. A., Fischer E., Calvano S. E., Fong Y., Moldawer L. L., Lowry S. F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 1993 Mar 1;150(5):1999–2006. [PubMed] [Google Scholar]
  9. Bauer J., Lengyel G., Bauer T. M., Acs G., Gerok W. Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes. FEBS Lett. 1989 May 22;249(1):27–30. doi: 10.1016/0014-5793(89)80008-0. [DOI] [PubMed] [Google Scholar]
  10. Baumann H., Wong G. G. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol. 1989 Aug 15;143(4):1163–1167. [PubMed] [Google Scholar]
  11. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 1987 Oct 23;238(4826):524–526. doi: 10.1126/science.2443979. [DOI] [PubMed] [Google Scholar]
  12. Bernardini R., Calogero A. E., Mauceri G., Chrousos G. P. Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner. Life Sci. 1990;47(17):1601–1607. doi: 10.1016/0024-3205(90)90190-3. [DOI] [PubMed] [Google Scholar]
  13. Bernton E. W., Beach J. E., Holaday J. W., Smallridge R. C., Fein H. G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 1987 Oct 23;238(4826):519–521. doi: 10.1126/science.2821620. [DOI] [PubMed] [Google Scholar]
  14. Bertini R., Bianchi M., Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med. 1988 May 1;167(5):1708–1712. doi: 10.1084/jem.167.5.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Besedovsky H., Sorkin E., Keller M., Müller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med. 1975 Nov;150(2):466–470. doi: 10.3181/00379727-150-39057. [DOI] [PubMed] [Google Scholar]
  16. Besedovsky H., del Rey A., Sorkin E., Dinarello C. A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986 Aug 8;233(4764):652–654. doi: 10.1126/science.3014662. [DOI] [PubMed] [Google Scholar]
  17. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  18. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985 Aug 30;229(4716):869–871. doi: 10.1126/science.3895437. [DOI] [PubMed] [Google Scholar]
  19. Beyaert R., Suffys P., Van Roy F., Fiers W. Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement. FEBS Lett. 1990 Mar 12;262(1):93–96. doi: 10.1016/0014-5793(90)80161-b. [DOI] [PubMed] [Google Scholar]
  20. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. doi: 10.1056/NEJM198709103171101. [DOI] [PubMed] [Google Scholar]
  21. Borth W., Luger T. A. Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin. J Biol Chem. 1989 Apr 5;264(10):5818–5825. [PubMed] [Google Scholar]
  22. Brouckaert P., Everaerdt B., Fiers W. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Eur J Immunol. 1992 Apr;22(4):981–986. doi: 10.1002/eji.1830220416. [DOI] [PubMed] [Google Scholar]
  23. Brown R., Li Z., Vriend C. Y., Nirula R., Janz L., Falk J., Nance D. M., Dyck D. G., Greenberg A. H. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1 beta: evidence for pituitary-adrenal and sympathetic control. Cell Immunol. 1991 Jan;132(1):84–93. doi: 10.1016/0008-8749(91)90008-y. [DOI] [PubMed] [Google Scholar]
  24. Brown Z., Strieter R. M., Chensue S. W., Ceska M., Lindley I., Neild G. H., Kunkel S. L., Westwick J. Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int. 1991 Jul;40(1):86–90. doi: 10.1038/ki.1991.184. [DOI] [PubMed] [Google Scholar]
  25. Castell J. V., Gómez-Lechón M. J., David M., Hirano T., Kishimoto T., Heinrich P. C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 1988 May 23;232(2):347–350. doi: 10.1016/0014-5793(88)80766-x. [DOI] [PubMed] [Google Scholar]
  26. Chambaut-Guérin A. M., Thomopoulos P. Regulation by dexamethasone and 1,25-dihydroxyvitamin D3 of the 75 kD-type A tumor necrosis factor receptor surface expression and mRNA level in human U937 cells. Eur Cytokine Netw. 1991 Nov-Dec;2(5):355–360. [PubMed] [Google Scholar]
  27. Coelho M. M., Souza G. E., Pelá I. R. Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol. 1992 Aug;263(2 Pt 2):R423–R427. doi: 10.1152/ajpregu.1992.263.2.R423. [DOI] [PubMed] [Google Scholar]
  28. Colić M., Drabek D. Expression and function of intercellular adhesion molecule 1 (ICAM-1) on rat thymic macrophages in culture. Immunol Lett. 1991 Jun;28(3):251–257. doi: 10.1016/0165-2478(91)90012-y. [DOI] [PubMed] [Google Scholar]
  29. Coyne D. W., Nickols M., Bertrand W., Morrison A. R. Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids. Am J Physiol. 1992 Jul;263(1 Pt 2):F97–102. doi: 10.1152/ajprenal.1992.263.1.F97. [DOI] [PubMed] [Google Scholar]
  30. Dayer J. M., de Rochemonteix B., Burrus B., Demczuk S., Dinarello C. A. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986 Feb;77(2):645–648. doi: 10.1172/JCI112350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. De Simoni M. G., Sironi M., De Luigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med. 1990 May 1;171(5):1773–1778. doi: 10.1084/jem.171.5.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Debets J. M., Ruers T. J., van der Linden M. P., van der Linden C. J., Buurman W. A. Inhibitory effect of corticosteroids on the secretion of tumour necrosis factor (TNF) by monocytes is dependent on the stimulus inducing TNF synthesis. Clin Exp Immunol. 1989 Nov;78(2):224–229. [PMC free article] [PubMed] [Google Scholar]
  33. Derijk R., Van Rooijen N., Tilders F. J., Besedovsky H. O., Del Rey A., Berkenbosch F. Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology. 1991 Jul;129(1):330–338. doi: 10.1210/endo-129-1-330. [DOI] [PubMed] [Google Scholar]
  34. Detmar M., Tenorio S., Hettmannsperger U., Ruszczak Z., Orfanos C. E. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol. 1992 Feb;98(2):147–153. doi: 10.1111/1523-1747.ep12555746. [DOI] [PubMed] [Google Scholar]
  35. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  36. Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N Engl J Med. 1993 Jan 14;328(2):106–113. doi: 10.1056/NEJM199301143280207. [DOI] [PubMed] [Google Scholar]
  37. Evans G. F., Zuckerman S. H. Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol. 1991 Sep;21(9):1973–1979. doi: 10.1002/eji.1830210902. [DOI] [PubMed] [Google Scholar]
  38. Ferran C., Dy M., Merite S., Sheehan K., Schreiber R., Leboulenger F., Landais P., Bluestone J., Bach J. F., Chatenoud L. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. Transplantation. 1990 Oct;50(4):642–648. doi: 10.1097/00007890-199010000-00023. [DOI] [PubMed] [Google Scholar]
  39. Flower R. J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988 Aug;94(4):987–1015. doi: 10.1111/j.1476-5381.1988.tb11614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gadina M., Bertini R., Mengozzi M., Zandalasini M., Mantovani A., Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med. 1991 Jun 1;173(6):1305–1310. doi: 10.1084/jem.173.6.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ghezzi P., Dinarello C. A. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma. J Immunol. 1988 Jun 15;140(12):4238–4244. [PubMed] [Google Scholar]
  42. Goppelt-Struebe M., Rehfeldt W. Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity. Biochim Biophys Acta. 1992 Jul 29;1127(2):163–167. doi: 10.1016/0005-2760(92)90273-x. [DOI] [PubMed] [Google Scholar]
  43. Gottschall P. E., Koves K., Mizuno K., Tatsuno I., Arimura A. Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line. Am J Physiol. 1991 Sep;261(3 Pt 1):E362–E368. doi: 10.1152/ajpendo.1991.261.3.E362. [DOI] [PubMed] [Google Scholar]
  44. HALBERG F., JOHNSON E. A., BROWN B. W., BITTNER J. J. Susceptibility rhythm to E. coli endotoxin and bioassay. Proc Soc Exp Biol Med. 1960 Jan;103:142–144. doi: 10.3181/00379727-103-25439. [DOI] [PubMed] [Google Scholar]
  45. Hamilton J. A., Piccoli D. S., Cebon J., Layton J. E., Rathanaswani P., McColl S. R., Leizer T. Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production. Blood. 1992 Mar 15;79(6):1413–1419. [PubMed] [Google Scholar]
  46. Hart P. H., Whitty G. A., Burgess D. R., Croatto M., Hamilton J. A. Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res. 1990 Summer;9(2):147–153. [PubMed] [Google Scholar]
  47. Hawes A. S., Rock C. S., Keogh C. V., Lowry S. F., Calvano S. E. In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infect Immun. 1992 Jul;60(7):2641–2647. doi: 10.1128/iai.60.7.2641-2647.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hepburn A., Boeynaems J. M., Fiers W., Dumont J. E. Modulation of tumor necrosis factor-alpha cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem Biophys Res Commun. 1987 Dec 16;149(2):815–822. doi: 10.1016/0006-291x(87)90440-2. [DOI] [PubMed] [Google Scholar]
  49. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Hurme M., Siljander P., Anttila H. Regulation of interleukin-1 beta production by glucocorticoids in human monocytes: the mechanism of action depends on the activation signal. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1383–1389. doi: 10.1016/s0006-291x(05)81349-x. [DOI] [PubMed] [Google Scholar]
  51. Jansen N. J., van Oeveren W., van den Broek L., Oudemans-van Straaten H. M., Stoutenbeek C. P., Joen M. C., Roozendaal K. J., Eysman L., Wildevuur C. R. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991 Oct;102(4):515–525. [PubMed] [Google Scholar]
  52. Jättelä M., Ilvesmäki V., Voutilainen R., Stenman U. H., Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology. 1991 Jan;128(1):623–629. doi: 10.1210/endo-128-1-623. [DOI] [PubMed] [Google Scholar]
  53. KRAUSS S. Response of serum haptoglobin to inflammation in adrenalectomized rat. Proc Soc Exp Biol Med. 1963 Mar;112:552–554. doi: 10.3181/00379727-112-28103. [DOI] [PubMed] [Google Scholar]
  54. Katsuura G., Gottschall P. E., Dahl R. R., Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology. 1988 May;122(5):1773–1779. doi: 10.1210/endo-122-5-1773. [DOI] [PubMed] [Google Scholar]
  55. Kawada N., Mizoguchi Y., Shin T., Tsutsui H., Kobayashi K., Morisawa S., Monna T., Yamamoto S. Interferon gamma stimulates prostaglandin E2 production by mouse Kupffer cells. Prostaglandins Leukot Essent Fatty Acids. 1990 Aug;40(4):275–279. doi: 10.1016/0952-3278(90)90049-q. [DOI] [PubMed] [Google Scholar]
  56. Kerner B., Teichmann B., Welte K. Dexamethasone inhibits tumor necrosis factor-induced granulocyte colony-stimulating factor production in human endothelial cells. Exp Hematol. 1992 Mar;20(3):334–338. [PubMed] [Google Scholar]
  57. Knudsen P. J., Dinarello C. A., Strom T. B. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol. 1987 Dec 15;139(12):4129–4134. [PubMed] [Google Scholar]
  58. Lazar G., Agarwal M. K. The influence of a novel glucocorticoid antagonist on endotoxin lethality in mice strains. Biochem Med Metab Biol. 1986 Aug;36(1):70–74. doi: 10.1016/0885-4505(86)90108-8. [DOI] [PubMed] [Google Scholar]
  59. Lazar G., Jr, Lazar G., Agarwal M. K. Modification of septic shock in mice by the antiglucocorticoid RU 38486. Circ Shock. 1992 Mar;36(3):180–184. [PubMed] [Google Scholar]
  60. Lee S. W., Tsou A. P., Chan H., Thomas J., Petrie K., Eugui E. M., Allison A. C. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1204–1208. doi: 10.1073/pnas.85.4.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Libert C., Van Bladel S., Brouckaert P., Fiers W. The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice. J Immunother (1991) 1991 Aug;10(4):227–235. doi: 10.1097/00002371-199108000-00001. [DOI] [PubMed] [Google Scholar]
  62. Luedke C. E., Cerami A. Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest. 1990 Oct;86(4):1234–1240. doi: 10.1172/JCI114829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Masferrer J. L., Zweifel B. S., Seibert K., Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest. 1990 Oct;86(4):1375–1379. doi: 10.1172/JCI114850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today. 1991 Feb;12(2):57–60. doi: 10.1016/0167-5699(91)90158-P. [DOI] [PubMed] [Google Scholar]
  65. Mefford I. N., Masters C. F., Heyes M. P., Eskay R. L. Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice. Brain Res. 1991 Aug 23;557(1-2):327–330. doi: 10.1016/0006-8993(91)90154-n. [DOI] [PubMed] [Google Scholar]
  66. Mier J. W., Vachino G., Klempner M. S., Aronson F. R., Noring R., Smith S., Brandon E. P., Laird W., Atkins M. B. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15;76(10):1933–1940. [PubMed] [Google Scholar]
  67. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  68. Moore R. N., Goodrum K. J., Berry L. J. Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc. 1976 Mar;19(3):187–197. [PubMed] [Google Scholar]
  69. Moore R. N., Goodrum K. J., Couch R. E., Jr, Berry L. J. Elicitation of endotoxemic effects in C3H/HeJ mice with glucocorticoid antagonizing factor and partial characterization of the factor. Infect Immun. 1978 Jan;19(1):79–86. doi: 10.1128/iai.19.1.79-86.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Mustafa M. M., Ramilo O., Sáez-Llorens X., Olsen K. D., Magness R. R., McCracken G. H., Jr Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990 Aug;144(8):883–887. doi: 10.1001/archpedi.1990.02150320047024. [DOI] [PubMed] [Google Scholar]
  71. Nakamura H., Motoyoshi S., Kadokawa T. Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats. Eur J Pharmacol. 1988 Jun 22;151(1):67–73. doi: 10.1016/0014-2999(88)90693-0. [DOI] [PubMed] [Google Scholar]
  72. Okamoto H., Ohashi Y., Itoh N. Involvement of leukocyte and glucocorticoid in the acute-phase response of angiotensinogen. Biochem Biophys Res Commun. 1987 Jun 30;145(3):1225–1230. doi: 10.1016/0006-291x(87)91568-3. [DOI] [PubMed] [Google Scholar]
  73. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988 Apr;81(4):1162–1172. doi: 10.1172/JCI113431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Parant M., Le Contel C., Parant F., Chedid L. Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha. Lymphokine Cytokine Res. 1991 Aug;10(4):265–271. [PubMed] [Google Scholar]
  75. Pedersen P., Hasselgren P. O., Li S. J., Hiyama D. T., Fischer J. E. Synthesis of acute-phase proteins in perfused liver following administration of recombinant interleukin 1 alpha to normal or adrenalectomized rats. J Surg Res. 1988 Oct;45(4):333–341. doi: 10.1016/0022-4804(88)90128-x. [DOI] [PubMed] [Google Scholar]
  76. Perlstein R. S., Mougey E. H., Jackson W. E., Neta R. Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 1991 Apr;10(1-2):141–146. [PubMed] [Google Scholar]
  77. Perretti M., Becherucci C., Scapigliati G., Parente L. The effect of adrenalectomy on interleukin-1 release in vitro and in vivo. Br J Pharmacol. 1989 Dec;98(4):1137–1142. doi: 10.1111/j.1476-5381.1989.tb12657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Perretti M., Mugridge K. G., Becherucci C., Parente L. Evidence that interleukin-1 and lipoxygenase metabolites mediate the lethal effect of complete Freund's adjuvant in adrenalectomized rats. Lymphokine Cytokine Res. 1991 Aug;10(4):239–243. [PubMed] [Google Scholar]
  79. Perretti M., Solito E., Parente L. Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions. 1992 Jan;35(1-2):71–78. doi: 10.1007/BF01990954. [DOI] [PubMed] [Google Scholar]
  80. Pfeilschifter J., Schwarzenbach H. Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett. 1990 Oct 29;273(1-2):185–187. doi: 10.1016/0014-5793(90)81080-8. [DOI] [PubMed] [Google Scholar]
  81. Plata-Salamán C. R. Dexamethasone inhibits food intake suppression induced by low doses of interleukin-1 beta administered intracerebroventricularly. Brain Res Bull. 1991 Nov;27(5):737–738. doi: 10.1016/0361-9230(91)90055-o. [DOI] [PubMed] [Google Scholar]
  82. Radomski M. W., Palmer R. M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A. 1990 Dec;87(24):10043–10047. doi: 10.1073/pnas.87.24.10043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Ramilo O., Sáez-Llorens X., Mertsola J., Jafari H., Olsen K. D., Hansen E. J., Yoshinaga M., Ohkawara S., Nariuchi H., McCracken G. H., Jr Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med. 1990 Aug 1;172(2):497–507. doi: 10.1084/jem.172.2.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Raz A., Wyche A., Siegel N., Needleman P. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem. 1988 Feb 25;263(6):3022–3028. [PubMed] [Google Scholar]
  85. Ribeiro R. A., Flores C. A., Cunha F. Q., Ferreira S. H. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology. 1991 Aug;73(4):472–477. [PMC free article] [PubMed] [Google Scholar]
  86. Richards C. D., Brown T. J., Shoyab M., Baumann H., Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol. 1992 Mar 15;148(6):1731–1736. [PubMed] [Google Scholar]
  87. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 1989 Dec;125(6):2800–2805. doi: 10.1210/endo-125-6-2800. [DOI] [PubMed] [Google Scholar]
  88. Rock C. S., Coyle S. M., Keogh C. V., Lazarus D. D., Hawes A. S., Leskiw M., Moldawer L. L., Stein T. P., Lowry S. F. Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. Surgery. 1992 Aug;112(2):467–474. [PubMed] [Google Scholar]
  89. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 1990 Oct 1;172(4):1193–1200. doi: 10.1084/jem.172.4.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Rupp R. G., Fuller G. M. The effects of leucocytic and serum factors on fibrinogen biosynthesis in cultured hepatocytes. Exp Cell Res. 1979 Jan;118(1):23–30. doi: 10.1016/0014-4827(79)90579-2. [DOI] [PubMed] [Google Scholar]
  91. Salkowski C. A., Vogel S. N. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol. 1992 Dec 15;149(12):4041–4047. [PubMed] [Google Scholar]
  92. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987 Oct 23;238(4826):522–524. doi: 10.1126/science.2821621. [DOI] [PubMed] [Google Scholar]
  93. Satoh M., Adachi K., Suda T., Yamazaki M., Mizuno D. TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol Biother. 1991 Sep;3(3):136–147. [PubMed] [Google Scholar]
  94. Satomi N., Sakurai A., Haranaka R., Haranaka K. Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor. J Biol Response Mod. 1988 Feb;7(1):54–64. [PubMed] [Google Scholar]
  95. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 1990 Feb 1;171(2):439–448. doi: 10.1084/jem.171.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Seitz M., Dewald B., Gerber N., Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest. 1991 Feb;87(2):463–469. doi: 10.1172/JCI115018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Sheagren J. N. Septic shock and corticosteroids. N Engl J Med. 1981 Aug 20;305(8):456–458. doi: 10.1056/NEJM198108203050810. [DOI] [PubMed] [Google Scholar]
  98. Sironi M., Gadina M., Kankova M., Riganti F., Mantovani A., Zandalasini M., Ghezzi P. Differential sensitivity of in vivo TNF and IL-6 production to modulation by anti-inflammatory drugs in mice. Int J Immunopharmacol. 1992 Aug;14(6):1045–1050. doi: 10.1016/0192-0561(92)90149-f. [DOI] [PubMed] [Google Scholar]
  99. Sobocinski P. Z., Canterbury W. J., Jr, Knutsen G. L., Hauer E. C. Effect of adrenalectomy on cadmium- and turpentine-induced hepatic synthesis of metallothionein and alpha 2-macrofetoprotein in the rat. Inflammation. 1981 Jun;5(2):153–164. doi: 10.1007/BF00914204. [DOI] [PubMed] [Google Scholar]
  100. Solito E., Parente L. Modulation of phospholipase A2 activity in human fibroblasts. Br J Pharmacol. 1989 Mar;96(3):656–660. doi: 10.1111/j.1476-5381.1989.tb11865.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Staruch M. J., Wood D. D. Reduction of serum Interleukin-1-like activity after treatment with dexamethasone. J Leukoc Biol. 1985 Feb;37(2):193–207. doi: 10.1002/jlb.37.2.193. [DOI] [PubMed] [Google Scholar]
  102. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Stith R. D., McCallum R. E. Down regulation of hepatic glucocorticoid receptors after endotoxin treatment. Infect Immun. 1983 May;40(2):613–621. doi: 10.1128/iai.40.2.613-621.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Suffys P., Beyaert R., Van Roy F., Fiers W. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem Biophys Res Commun. 1987 Dec 16;149(2):735–743. doi: 10.1016/0006-291x(87)90429-3. [DOI] [PubMed] [Google Scholar]
  105. Sundar S. K., Becker K. J., Cierpial M. A., Carpenter M. D., Rankin L. A., Fleener S. L., Ritchie J. C., Simson P. E., Weiss J. M. Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6398–6402. doi: 10.1073/pnas.86.16.6398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Sundar S. K., Cierpial M. A., Kilts C., Ritchie J. C., Weiss J. M. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci. 1990 Nov;10(11):3701–3706. doi: 10.1523/JNEUROSCI.10-11-03701.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Theisen-Popp P., Pape H., Müller-Peddinghaus R. Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation. Int J Immunopharmacol. 1992 May;14(4):565–571. doi: 10.1016/0192-0561(92)90117-4. [DOI] [PubMed] [Google Scholar]
  108. Tobler A., Meier R., Seitz M., Dewald B., Baggiolini M., Fey M. F. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood. 1992 Jan 1;79(1):45–51. [PubMed] [Google Scholar]
  109. Toth L. A., Gardiner T. W., Krueger J. M. Modulation of sleep by cortisone in normal and bacterially infected rabbits. Am J Physiol. 1992 Dec;263(6 Pt 2):R1339–R1346. doi: 10.1152/ajpregu.1992.263.6.R1339. [DOI] [PubMed] [Google Scholar]
  110. Tracey D. E., Hardee M. M., Richard K. A., Paslay J. W. Pharmacological inhibition of interleukin-1 activity on T cells by hydrocortisone, cyclosporine, prostaglandins, and cyclic nucleotides. Immunopharmacology. 1988 Jan-Feb;15(1):47–62. doi: 10.1016/0162-3109(88)90042-2. [DOI] [PubMed] [Google Scholar]
  111. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  112. Tsagarakis S., Gillies G., Rees L. H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology. 1989 Jan;49(1):98–101. doi: 10.1159/000125096. [DOI] [PubMed] [Google Scholar]
  113. Ulich T. R., Guo K. Z., Irwin B., Remick D. G., Davatelis G. N. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am J Pathol. 1990 Nov;137(5):1173–1185. [PMC free article] [PubMed] [Google Scholar]
  114. Villiger P. M., Terkeltaub R., Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest. 1992 Aug;90(2):488–496. doi: 10.1172/JCI115885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Waage A., Slupphaug G., Shalaby R. Glucocorticoids inhibit the production of IL6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol. 1990 Nov;20(11):2439–2443. doi: 10.1002/eji.1830201112. [DOI] [PubMed] [Google Scholar]
  116. Weidenfeld J., Abramsky O., Ovadia H. Effect of interleukin-1 on ACTH and corticosterone secretion in dexamethasone and adrenalectomized pretreated male rats. Neuroendocrinology. 1989 Dec;50(6):650–654. doi: 10.1159/000125294. [DOI] [PubMed] [Google Scholar]
  117. Woloski B. M., Smith E. M., Meyer W. J., 3rd, Fuller G. M., Blalock J. E. Corticotropin-releasing activity of monokines. Science. 1985 Nov 29;230(4729):1035–1037. doi: 10.1126/science.2997929. [DOI] [PubMed] [Google Scholar]
  118. Zabel P., Horst H. J., Kreiker C., Schlaak M. Circadian rhythm of interleukin-1 production of monocytes and the influence of endogenous and exogenous glucocorticoids in man. Klin Wochenschr. 1990 Dec 17;68(24):1217–1221. doi: 10.1007/BF01796513. [DOI] [PubMed] [Google Scholar]
  119. Zuckerman S. H., Evans G. F., Butler L. D. Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun. 1991 Aug;59(8):2774–2780. doi: 10.1128/iai.59.8.2774-2780.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. van der Meer J. W., Barza M., Wolff S. M., Dinarello C. A. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1620–1623. doi: 10.1073/pnas.85.5.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES